This inventor holds 17 USPTO granted patents, plus 1 CIPO patent, primarily in Pharmaceutical Compositions. Top assignees: Abbott Laboratories Corporation, Abbvie Inc., Other. Active years: 1993-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Libertyville, IL (US) (1993 - 1998)
- Deerfield, IL (US) (2002 - 2014)
Company Filing History:
15 out of 4,190 
1 out of 827 
1 out of 834,601 Years Active: 1993-2014
Areas of Expertise:
Title: Paul E. Wiedeman: Pioneering Innovations in Pharmaceutical Chemistry
Introduction
Paul E. Wiedeman, an accomplished inventor based in Deerfield, IL, has made significant strides in the field of pharmaceutical chemistry. With a remarkable portfolio of 17 patents, his work primarily focuses on innovative treatments for diabetes and related health conditions. His inventions showcase the potential of modern medicine to address chronic diseases effectively.
Latest Patents
Among his notable contributions, Wiedeman's recent patents include formulations that serve as inhibitors of dipeptidyl peptidase-IV (DPP-IV). These compounds are not only groundbreaking but essential for the prevention and treatment of type II diabetes, hyperglycemia, Syndrome X, hyperinsulinemia, obesity, atherosclerosis, and various immunomodulatory diseases. His research emphasizes the development of pharmaceutical compositions that can significantly improve health outcomes for patients suffering from these conditions.
Career Highlights
Throughout his career, Paul E. Wiedeman has worked with esteemed organizations, most notably Abbott Laboratories Corporation, where he has leveraged his expertise in drug development. His dedication to innovation and quality has enabled the creation of effective pharmaceutical solutions that have the potential to transform patient care.
Collaborations
Wiedeman has collaborated with other prominent scientists in the field, including Hing L. Sham and Jay R. Luly. These partnerships reflect a strong network of professionals dedicated to advancing pharmaceutical research and enhancing therapeutic options in medicine.
Conclusion
Through his innovative patents and collaborations, Paul E. Wiedeman has played a pivotal role in the ongoing fight against diabetes and related diseases. His work continues to inspire future inventors in the pharmaceutical industry, showcasing the importance of innovation in improving health and quality of life.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile